{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:31:08Z","timestamp":1793971868575,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54334-7","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T10:52:36Z","timestamp":1732359156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3260-2631","authenticated-orcid":false,"given":"Gagandeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-6806","authenticated-orcid":false,"given":"Juan","family":"Garc\u00eda-Bernalt Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5571-8277","authenticated-orcid":false,"given":"Prajakta","family":"Warang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3287-3987","authenticated-orcid":false,"given":"Lauren A.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz","family":"Noureddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Laghlali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonina","family":"Bykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9608-789X","authenticated-orcid":false,"given":"Matthew","family":"Prellberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0397-623X","authenticated-orcid":false,"given":"Vivian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarabjot","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4193-1042","authenticated-orcid":false,"given":"Lars","family":"Pache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9400-746X","authenticated-orcid":false,"given":"Sara","family":"Cuadrado-Castano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-1827","authenticated-orcid":false,"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-3132","authenticated-orcid":false,"given":"Michael","family":"Schotsaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"54334_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov, P. V. et al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 21, 361\u2013379 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"54334_CR2","doi-asserted-by":"publisher","first-page":"e1830","DOI":"10.1093\/cid\/ciaa1846","volume":"73","author":"LJ Abu-Raddad","year":"2021","unstructured":"Abu-Raddad, L. J. et al. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting. Clin. Infect. Dis. 73, e1830\u2013e1840 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"54334_CR3","doi-asserted-by":"publisher","unstructured":"Babiker, A., Marvil, C. E., Waggoner, J. J., Collins, M. H. & Piantadosi, A. The Importance and Challenges of Identifying SARS-CoV-2 Reinfections. J. Clin. Microbiol. 59, https:\/\/doi.org\/10.1128\/jcm.02769-20 (2021).","DOI":"10.1128\/jcm.02769-20"},{"key":"54334_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/22221751.2022.2052358","volume":"11","author":"NN Nguyen","year":"2022","unstructured":"Nguyen, N. N. et al. SARS-CoV-2 reinfection and COVID-19 severity. Emerg. Microbes Infect. 11, 894\u2013901 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"54334_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0140-6736(22)02465-5","volume":"401","author":"C Stein","year":"2023","unstructured":"Stein, C. et al. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet 401, 833\u2013842 (2023).","journal-title":"Lancet"},{"key":"54334_CR6","doi-asserted-by":"crossref","unstructured":"Hwang, J. H. et al. Influenza viral infection is a risk factor for severe illness in COVID-19 patients: a nationwide population-based cohort study. Emerg. Microbes Infect. 12, 2164215 (2023).","DOI":"10.1080\/22221751.2022.2164215"},{"key":"54334_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","volume":"29","author":"CD Russell","year":"2023","unstructured":"Russell, C. D., Lone, N. I. & Baillie, J. K. Comorbidities, multimorbidity and COVID-19. Nat. Med. 29, 334\u2013343 (2023).","journal-title":"Nat. Med."},{"key":"54334_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03647-20","volume":"12","author":"WH Ng","year":"2021","unstructured":"Ng, W. H. et al. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis. mBio 12, e03647-20 (2021).","journal-title":"mBio"},{"key":"54334_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41590-021-01030-z","volume":"23","author":"E Andreakos","year":"2022","unstructured":"Andreakos, E. et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nat. Immunol. 23, 159\u2013164 (2022).","journal-title":"Nat. Immunol."},{"key":"54334_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/imr.12897","volume":"296","author":"IG Ovsyannikova","year":"2020","unstructured":"Ovsyannikova, I. G., Haralambieva, I. H., Crooke, S. N., Poland, G. A. & Kennedy, R. B. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol. Rev. 296, 205\u2013219 (2020).","journal-title":"Immunol. Rev."},{"key":"54334_CR11","doi-asserted-by":"crossref","unstructured":"Diego, J. G.-B. et al. Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters. PLoS Pathog. 20, e1011805 (2024).","DOI":"10.1371\/journal.ppat.1011805"},{"key":"54334_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13845","volume":"52","author":"ME Flacco","year":"2022","unstructured":"Flacco, M. E. et al. Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis. Eur. J. Clin. Invest. 52, e13845 (2022).","journal-title":"Eur. J. Clin. Invest."},{"key":"54334_CR13","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.lanepe.2022.100453","volume":"20","author":"S Medi\u0107","year":"2022","unstructured":"Medi\u0107, S. et al. Risk and severity of SARS-CoV-2 reinfections during 2020\u20132022 in Vojvodina, Serbia: A population-level observational study. Lancet Reg. Health Eur. 20, 100453 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"54334_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/science.abn4947","volume":"376","author":"JRC Pulliam","year":"2022","unstructured":"Pulliam, J. R. C. et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 376, eabn4947 (2022).","journal-title":"Science"},{"key":"54334_CR15","doi-asserted-by":"publisher","first-page":"e2260","DOI":"10.1002\/rmv.2260","volume":"32","author":"E O Murchu","year":"2022","unstructured":"O Murchu, E. et al. Quantifying the risk of SARS-CoV-2 reinfection over time. Rev. Med. Virol. 32, e2260 (2022).","journal-title":"Rev. Med. Virol."},{"key":"54334_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1099\/jgv.0.001439","volume":"101","author":"P Kellam","year":"2020","unstructured":"Kellam, P. & Barclay, W. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. J. Gen. Virol. 101, 791\u2013797 (2020).","journal-title":"J. Gen. Virol."},{"key":"54334_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","volume":"586","author":"C Mu\u00f1oz-Fontela","year":"2020","unstructured":"Mu\u00f1oz-Fontela, C. et al. Animal models for COVID-19. Nature 586, 509\u2013515 (2020).","journal-title":"Nature"},{"key":"54334_CR18","unstructured":"Halfmann, P. J. et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature. 603, 687\u2013692 (2022) ."},{"key":"54334_CR19","unstructured":"Rathnasinghe R. et al. Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera. Nat. Commun 13, 3921 (2022)."},{"key":"54334_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.coviro.2015.06.009","volume":"13","author":"LM Gretebeck","year":"2015","unstructured":"Gretebeck, L. M. & Subbarao, K. Animal models for SARS and MERS coronaviruses. Curr. Opin. Virol. 13, 123\u2013129 (2015).","journal-title":"Curr. Opin. Virol."},{"key":"54334_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s12250-020-00252-z","volume":"35","author":"A Singh","year":"2020","unstructured":"Singh, A. et al. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virol. Sin. 35, 290\u2013304 (2020).","journal-title":"Virol. Sin."},{"key":"54334_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5501\/wjv.v11.i1.40","volume":"11","author":"UB Saravanan","year":"2022","unstructured":"Saravanan, U. B., Namachivayam, M., Jeewon, R., Huang, J.-D. & Durairajan, S. S. K. Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation. World J. Virol. 11, 40\u201356 (2022).","journal-title":"World J. Virol."},{"key":"54334_CR23","doi-asserted-by":"crossref","unstructured":"Venkataraman, T., Coleman, C. M. & Frieman, M. B. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection. J. Virol. 91, e00182-17 (2017).","DOI":"10.1128\/JVI.00182-17"},{"key":"54334_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41590-023-01428-x","volume":"24","author":"T Wang","year":"2023","unstructured":"Wang, T. et al. Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs. Nat. Immunol. 24, 423\u2013438 (2023).","journal-title":"Nat. Immunol."},{"key":"54334_CR25","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41590-023-01602-1","volume":"24","author":"CS Iliakis","year":"2023","unstructured":"Iliakis, C. S. et al. The role of recruitment versus training in influenza-induced lasting changes to alveolar macrophage function. Nat. Immunol. 24, 1639\u20131641 (2023).","journal-title":"Nat. Immunol."},{"key":"54334_CR26","doi-asserted-by":"crossref","unstructured":"Hua, X. et al. Nasal priming by a murine coronavirus provides protective immunity against lethal heterologous virus pneumonia. JCI Insight 3, e99025 (2018).","DOI":"10.1172\/jci.insight.99025"},{"key":"54334_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1534\/genetics.111.129221","volume":"189","author":"H Xiong","year":"2011","unstructured":"Xiong, H. et al. A flexible estimating equations approach for mapping function-valued traits. Genetics 189, 305\u2013316 (2011).","journal-title":"Genetics"},{"key":"54334_CR28","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/jbmr.72","volume":"25","author":"CL Ackert-Bicknell","year":"2010","unstructured":"Ackert-Bicknell, C. L. et al. Mouse BMD quantitative trait loci show improved concordance with human genome-wide association loci when recalculated on a new, common mouse genetic map. J. Bone Miner. Res. J. Am. Soc. Bone Miner. Res. 25, 1808\u20131820 (2010).","journal-title":"J. Bone Miner. Res. J. Am. Soc. Bone Miner. Res."},{"key":"54334_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00335-012-9394-2","volume":"23","author":"EJ Chesler","year":"2012","unstructured":"Chesler, E. J. et al. Quantitative trait loci for sensitivity to ethanol intoxication in a C57BL\/6J\u00d7129S1\/SvImJ inbred mouse cross. Mamm. Genome. J. Int. Mamm. Genome Soc. 23, 305\u2013321 (2012).","journal-title":"Mamm. Genome. J. Int. Mamm. Genome Soc."},{"key":"54334_CR30","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1194\/jlr.M400098-JLR200","volume":"45","author":"N Ishimori","year":"2004","unstructured":"Ishimori, N. et al. Quantitative trait loci that determine plasma lipids and obesity in C57BL\/6J and 129S1\/SvImJ inbred mice. J. Lipid Res. 45, 1624\u20131632 (2004).","journal-title":"J. Lipid Res."},{"key":"54334_CR31","doi-asserted-by":"publisher","first-page":"L32","DOI":"10.1152\/ajplung.00390.2002","volume":"285","author":"GS Whitehead","year":"2003","unstructured":"Whitehead, G. S., Walker, J. K. L., Berman, K. G., Foster, W. M. & Schwartz, D. A. Allergen-induced airway disease is mouse strain dependent. Am. J. Physiol. -Lung Cell. Mol. Physiol. 285, L32\u2013L42 (2003).","journal-title":"Am. J. Physiol. -Lung Cell. Mol. Physiol."},{"key":"54334_CR32","doi-asserted-by":"crossref","unstructured":"Clough, B. et al. C57BL\/6 and 129 inbred mouse strains\u2026 Wellcome Open Res. 4, 124 (2019).","DOI":"10.12688\/wellcomeopenres.15329.1"},{"key":"54334_CR33","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.chom.2016.02.019","volume":"19","author":"C Krapp","year":"2016","unstructured":"Krapp, C. et al. Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity. Cell Host Microbe 19, 504\u2013514 (2016).","journal-title":"Cell Host Microbe"},{"key":"54334_CR34","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.celrep.2019.04.063","volume":"27","author":"E Braun","year":"2019","unstructured":"Braun, E. et al. Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins. Cell Rep. 27, 2092\u20132104.e10 (2019).","journal-title":"Cell Rep."},{"key":"54334_CR35","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1096\/fj.11-189886","volume":"26","author":"A Nordmann","year":"2012","unstructured":"Nordmann, A., Wixler, L., Boergeling, Y., Wixler, V. & Ludwig, S. A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. FASEB J. 26, 1290\u20131300 (2012).","journal-title":"FASEB J."},{"key":"54334_CR36","doi-asserted-by":"publisher","first-page":"105633","DOI":"10.1016\/j.compbiomed.2022.105633","volume":"146","author":"M Kandeel","year":"2022","unstructured":"Kandeel, M. & El-Deeb, W. Omicron variant receptor-binding domain phylogenetics and molecular dynamics. Comput. Biol. Med. 146, 105633 (2022).","journal-title":"Comput. Biol. Med."},{"key":"54334_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40009-022-01123-9","volume":"45","author":"G Gupta","year":"2022","unstructured":"Gupta, G. et al. Th1\/Th2\/Th17 Cytokine Profile among Different Stages of COVID-19 Infection. Natl Acad. Sci. Lett. 45, 363\u2013369 (2022).","journal-title":"Natl Acad. Sci. Lett."},{"key":"54334_CR38","doi-asserted-by":"crossref","unstructured":"Ling, L. et al. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19. Front. Immunol. 12, 763292 (2021).","DOI":"10.3389\/fimmu.2021.763292"},{"key":"54334_CR39","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","volume":"9","author":"H Han","year":"2020","unstructured":"Han, H. et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microbes Infect. 9, 1123\u20131130 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"54334_CR40","unstructured":"Queiroz, M. A. F. et al. Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome. Front. Cell. Infect. Microbiol. 12, 922422 (2022)."},{"key":"54334_CR41","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin, C. et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 71, 762\u2013768 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"54334_CR42","doi-asserted-by":"publisher","first-page":"155323","DOI":"10.1016\/j.cyto.2020.155323","volume":"137","author":"A Ghazavi","year":"2021","unstructured":"Ghazavi, A., Ganji, A., Keshavarzian, N., Rabiemajd, S. & Mosayebi, G. Cytokine profile and disease severity in patients with COVID-19. Cytokine 137, 155323 (2021).","journal-title":"Cytokine"},{"key":"54334_CR43","doi-asserted-by":"crossref","unstructured":"Davidson, S., Crotta, S., McCabe, T. M. & Wack, A. Pathogenic potential of interferon \u03b1\u03b2 in acute influenza infection. Nat. Commun. 5, 3864 (2014).","DOI":"10.1038\/ncomms4864"},{"key":"54334_CR44","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/s41591-021-01488-2","volume":"27","author":"P B\u00e9gin","year":"2021","unstructured":"B\u00e9gin, P. et al. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nat. Med. 27, 2012\u20132024 (2021).","journal-title":"Nat. Med."},{"key":"54334_CR45","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/all.14364","volume":"75","author":"AK Azkur","year":"2020","unstructured":"Azkur, A. K. et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 75, 1564\u20131581 (2020).","journal-title":"Allergy"},{"key":"54334_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06015-9","volume":"21","author":"C Dentone","year":"2021","unstructured":"Dentone, C. et al. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy. BMC Infect. Dis. 21, 353 (2021).","journal-title":"BMC Infect. Dis."},{"key":"54334_CR47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"54334_CR48","doi-asserted-by":"crossref","unstructured":"Ochando, J., Mulder, W. J. M., Madsen, J. C., Netea, M. G. & Duivenvoorden, R. Trained immunity \u2014 basic concepts and contributions to immunopathology. Nat. Rev. Nephrol. 19, 23\u201337 (2023).","DOI":"10.1038\/s41581-022-00633-5"},{"key":"54334_CR49","doi-asserted-by":"crossref","unstructured":"Aegerter, H. et al. Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection. Nat. Immunol. 21, 145\u2013157 (2020).","DOI":"10.1038\/s41590-019-0568-x"},{"key":"54334_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/2040622315609251","volume":"7","author":"L George","year":"2016","unstructured":"George, L. & Brightling, C. E. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther. Adv. Chronic Dis. 7, 34\u201351 (2016).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"54334_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1471-2466-14-112","volume":"14","author":"O Eltboli","year":"2014","unstructured":"Eltboli, O. et al. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils. BMC Pulm. Med. 14, 112 (2014).","journal-title":"BMC Pulm. Med."},{"key":"54334_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jaci.2010.03.026","volume":"126","author":"NS Kulkarni","year":"2010","unstructured":"Kulkarni, N. S. et al. Eosinophil protein in airway macrophages: A novel biomarker of eosinophilic inflammation in patients with asthma. J. Allergy Clin. Immunol. 126, 61\u201369.e3 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"54334_CR53","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jaci.2018.01.029","volume":"142","author":"JM Felton","year":"2018","unstructured":"Felton, J. M. et al. Mer-mediated eosinophil efferocytosis regulates resolution of allergic airway inflammation. J. Allergy Clin. Immunol. 142, 1884\u20131893.e6 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"54334_CR54","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.gastro.2003.07.007","volume":"125","author":"A Mishra","year":"2003","unstructured":"Mishra, A. & Rothenberg, M. E. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism1. Gastroenterology 125, 1419\u20131427 (2003).","journal-title":"Gastroenterology"},{"key":"54334_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1165\/rcmb.2005-0474OC","volume":"35","author":"PC Fulkerson","year":"2006","unstructured":"Fulkerson, P. C., Fischetti, C. A., Hassman, L. M., Nikolaidis, N. M. & Rothenberg, M. E. Persistent Effects Induced by IL-13 in the Lung. Am. J. Respir. Cell Mol. Biol. 35, 337\u2013346 (2006).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"54334_CR56","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1172\/JCI5909","volume":"103","author":"Z Zhu","year":"1999","unstructured":"Zhu, Z. et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103, 779\u2013788 (1999).","journal-title":"J. Clin. Invest."},{"key":"54334_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","volume":"18","author":"RL Gieseck","year":"2018","unstructured":"Gieseck, R. L., Wilson, M. S. & Wynn, T. A. Type 2 immunity in tissue repair and fibrosis. Nat. Rev. Immunol. 18, 62\u201376 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"54334_CR58","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.4049\/jimmunol.0903008","volume":"184","author":"SK Madala","year":"2010","unstructured":"Madala, S. K. et al. Matrix Metalloproteinase 12-Deficiency Augments Extracellular Matrix Degrading Metalloproteinases and Attenuates IL-13\u2013Dependent Fibrosis. J. Immunol. 184, 3955\u20133963 (2010).","journal-title":"J. Immunol."},{"key":"54334_CR59","doi-asserted-by":"crossref","unstructured":"Mommert, S., Ratz, L., Stark, H., Gutzmer, R. & Werfel, T. The histamine H4 receptor modulates the differentiation process of human monocyte-derived M1 macrophages and the release of CCL4\/MIP-1\u03b2 from fully differentiated M1 macrophages. Inflamm. Res. 67, 503\u2013513 (2018).","DOI":"10.1007\/s00011-018-1140-0"},{"key":"54334_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/intimm\/dxw012","volume":"28","author":"H Kawano","year":"2016","unstructured":"Kawano, H. et al. IL-10-producing lung interstitial macrophages prevent neutrophilic asthma. Int. Immunol. 28, 489\u2013501 (2016).","journal-title":"Int. Immunol."},{"key":"54334_CR61","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/1521-4141(200002)30:2<382::AID-IMMU382>3.0.CO;2-L","volume":"30","author":"X Yang","year":"2000","unstructured":"Yang, X., Wang, S., Fan, Y. & Han, X. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur. J. Immunol. 30, 382\u2013391 (2000).","journal-title":"Eur. J. Immunol."},{"key":"54334_CR62","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.4049\/jimmunol.165.5.2783","volume":"165","author":"FN Lauw","year":"2000","unstructured":"Lauw, F. N. et al. Proinflammatory Effects of IL-10 During Human Endotoxemia1. J. Immunol. 165, 2783\u20132789 (2000).","journal-title":"J. Immunol."},{"key":"54334_CR63","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/gut.50.2.191","volume":"50","author":"H Tilg","year":"2002","unstructured":"Tilg, H. et al. Treatment of Crohn\u2019s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon \u03b3. Gut 50, 191\u2013195 (2002).","journal-title":"Gut"},{"key":"54334_CR64","doi-asserted-by":"publisher","first-page":"35466","DOI":"10.1074\/jbc.M206395200","volume":"277","author":"CG Lee","year":"2002","unstructured":"Lee, C. G. et al. Transgenic Overexpression of Interleukin (IL)-10 in the Lung Causes Mucus Metaplasia, Tissue Inflammation, and Airway Remodeling via IL-13-dependent and -independent Pathways *. J. Biol. Chem. 277, 35466\u201335474 (2002).","journal-title":"J. Biol. Chem."},{"key":"54334_CR65","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.jaci.2012.01.052","volume":"129","author":"M Crapster-Pregont","year":"2012","unstructured":"Crapster-Pregont, M., Yeo, J., Sanchez, R. L. & Kuperman, D. A. Dendritic cells and alveolar macrophages mediate IL-13\u2013induced airway inflammation and chemokine production. J. Allergy Clin. Immunol. 129, 1621\u20137.e3 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"54334_CR66","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.4049\/jimmunol.167.3.1769","volume":"167","author":"JG Ford","year":"2001","unstructured":"Ford, J. G. et al. IL-13 and IFN-\u03b3: Interactions in Lung Inflammation1. J. Immunol. 167, 1769\u20131777 (2001).","journal-title":"J. Immunol."},{"key":"54334_CR67","first-page":"530","volume":"9","author":"TK Varma","year":"2002","unstructured":"Varma, T. K., Lin, C. Y., Toliver-Kinsky, T. E. & Sherwood, E. R. Endotoxin-Induced Gamma Interferon Production: Contributing Cell Types and Key Regulatory Factors. Clin. Diagn. Lab. Immunol. 9, 530\u2013543 (2002).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"54334_CR68","doi-asserted-by":"crossref","unstructured":"Luo, X. et al. Brucella Downregulates Tumor Necrosis Factor-\u03b1 to Promote Intracellular Survival via Omp25 Regulation of Different MicroRNAs in Porcine and Murine Macrophages. Front. Immunol. 8, 2013 (2018).","DOI":"10.3389\/fimmu.2017.02013"},{"key":"54334_CR69","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1128\/jvi.70.4.2650-2653.1996","volume":"70","author":"H Adler","year":"1996","unstructured":"Adler, H. et al. Cytokine regulation by virus infection: bovine viral diarrhea virus, a flavivirus, downregulates production of tumor necrosis factor alpha in macrophages in vitro. J. Virol. 70, 2650\u20132653 (1996).","journal-title":"J. Virol."},{"key":"54334_CR70","doi-asserted-by":"publisher","first-page":"ftw111","DOI":"10.1093\/femspd\/ftw111","volume":"74","author":"M Valeri","year":"2016","unstructured":"Valeri, M. & Raffatellu, M. Cytokines IL-17 and IL-22 in the host response to infection. Pathog. Dis. 74, ftw111 (2016).","journal-title":"Pathog. Dis."},{"key":"54334_CR71","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","volume":"6","author":"A Shimabukuro-Vornhagen","year":"2018","unstructured":"Shimabukuro-Vornhagen, A. et al. Cytokine release syndrome. J. Immunother. Cancer 6, 56 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"54334_CR72","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1093\/bioinformatics\/btab705","volume":"37","author":"H Li","year":"2021","unstructured":"Li, H. New strategies to improve minimap2 alignment accuracy. Bioinformatics 37, 4572\u20134574 (2021).","journal-title":"Bioinformatics"},{"key":"54334_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, giab008 (2021).","journal-title":"GigaScience"},{"key":"54334_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1910-1","volume":"20","author":"S Kovaka","year":"2019","unstructured":"Kovaka, S. et al. Transcriptome assembly from long-read RNA-seq alignments with StringTie2. Genome Biol. 20, 278 (2019).","journal-title":"Genome Biol."},{"key":"54334_CR75","unstructured":"davidsjoberg\/ggsankey: Sankey, Alluvial and Sankey Bump Plots version 0.0.99999 from GitHub. https:\/\/rdrr.io\/github\/davidsjoberg\/ggsankey\/."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54334-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T12:02:04Z","timestamp":1732363324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54334-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54334"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54334-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3637405\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"19 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The M.S. laboratory has received unrelated funding support in sponsored research agreements from Phio Pharmaceuticals, 7Hills Pharma, ArgenX BV and Moderna. The A.G.-S. laboratory has received research support from GSK, Pfizer, Senhwa Biosciences, Kenall Manufacturing, Blade Therapeutics, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck, outside of the reported work. A.G.-S. has consulting agreements for the following companies involving cash and\/or stock: Castlevax, Amovir, Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, CureLab Oncology, CureLab Veterinary, Synairgen, Paratus and Pfizer, outside of the reported work. A.G.-S. has been an invited speaker in meeting events organized by Seqirus, Janssen, Abbott and Astrazeneca. A.G.-S. is inventor on patents and patent applications on the use of antivirals and vaccines for the treatment and prevention of virus infections and cancer, owned by the Icahn School of Medicine at Mount Sinai, New York. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10178"}}